- Vitreoretinal surgery
- Medical retina
- Age-related macular degeneration
- Diabetic eye disease
- Surgical vitreoretinal disease
He undertakes cataract surgery and has a sub-specialty interest in macular and retinal surgery. He is a HEFCE Senior Lecturer at King's College London, part of the King's Health Partners, the UK's largest Academic Health Science Centre.
Current interests include studies of ocular macromolecular diffusion and drug modification in relation to the pharmacotherapy of age-related macular degeneration (AMD), ocular safety testing using cell culture techniques, and studies investigating the vitreomacular interface and how this influences wet AMD.
He is Editor-in-Chief of the Moorfields Manual of Ophthalmology. He is actively involved in clinical reseach and leads the MERLOT study of epimacular brachytherapy, one of the country's largest randomised controlled trials in ophthalmology.
He has been closely involved in key studies of stereotactic radiotherapy for wet AMD, and the use of ocriplasmin for pharmacological vitreolysis. More recently he has been involved in the clinical trial of subretinal implants, the so-called 'bionic eye'.
Mr Jacksonsupervises clinicians undertaking MDs and PhDs, serves as a specialist advisor to NICE, and is engaged as a Key Opinion Leader by Industry.
Consultant Ophthalmic SurgeonKing's College Hospital
HEFCE Senior Clinical LecturerKing's College London (University of London)
Lead for undergraduate Ophthalmology teachingSchool of Medicine, King's College London
Clinical LecturerSchool of Optometry
MD and PhD supervisorKing's College London (University of London)
Otago University (New Zealand)1993
Treatment enquiries: +44 (0) 207 616 7693Consultant appointments: +44 (0) 207 616 7693 Prices for self funding patients: +44 (0) 203 219 3315Physiotherapy appointments: +44 (0) 207 616 7651 X-ray and scan appointments: +44 (0) 207 616 7653Invoice and payment enquiries: +44 (0) 207 616 7708